High-dose budesonide for early COVID-19 – Authors' reply Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- December 2021
has subject area
- 11 Medical and Health Sciences (FoR)
- Anti-Asthmatic Agents (MeSH)
- Budesonide (MeSH)
- COVID-19 (MeSH)
- Formoterol Fumarate (MeSH)
- General & Internal Medicine (Science Metrix)
- Humans (MeSH)
- SARS-CoV-2 (MeSH)
published in
- The Lancet Journal